Denali Therapeutics - Stock Price History | DNLI

Historical daily share price chart and data for Denali Therapeutics since 2021 adjusted for splits. The latest closing stock price for Denali Therapeutics as of September 27, 2021 is 51.83.
  • The all-time high Denali Therapeutics stock closing price was 93.56 on December 22, 2020.
  • The Denali Therapeutics 52-week high stock price is 93.94, which is 81.2% above the current share price.
  • The Denali Therapeutics 52-week low stock price is 35.48, which is 31.5% below the current share price.
  • The average Denali Therapeutics stock price for the last 52 weeks is 61.37.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Denali Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 33.8775 16.3900 93.5600 14.2000 83.7600 380.83%
2019 19.7455 19.3300 28.1400 14.4000 17.4200 -15.68%
2018 18.5057 16.1300 24.8000 12.4600 20.6600 32.10%
2017 17.9720 21.4500 21.4500 15.0400 15.6400 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.305B $0.336B
Denali Therapeutics Inc. is a biotechnology company. It focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and others. Denali Therapeutics Inc. is based in SOUTH SAN FRANCISCO, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29